MONDAY, Aug. 30, 2021 (HealthDay News) — Treatment with two monoclonal antibodies lowers the odds of hospitalization for high-risk COVID-19 patients with mild to moderate illness, according to a new study. “Our conclusion overall at this point is that monoclonal antibodies are an important option in treatment to reduce theContinue Reading

FRIDAY, Aug. 27, 2021 (HealthDay News) — A first-of-a-kind nerve stimulation treatment for people who have problems moving their arms after a stroke has been approved by the U.S. Food and Drug Administration. “People who have lost mobility in their hands and arms due to ischemic stroke are often limitedContinue Reading

THURSDAY, Aug. 26, 2021 (HealthDay News) — A new approach to spinal cord stimulation may drastically reduce chronic back pain, a small pilot study suggests. The study, of 20 patients with stubborn low back pain, tested the effects of implanting electrodes near the spinal cord to stimulate it with “ultra-low”Continue Reading

FRIDAY, Aug. 20, 2021 (HealthDay News) — Men with chronic pain from prostate inflammation may get lasting relief from acupuncture, a new clinical trial finds. At issue is a condition known as chronic prostatitis/chronic pelvic pain syndrome, in which the prostate gland becomes inflamed and nerves supplying the area areContinue Reading

FRIDAY, Aug. 20, 2021 (HealthDay News) — Early treatment with COVID-19 survivors’ blood plasma doesn’t prevent disease progression in people who have mild COVID-19 symptoms but are at risk for more severe illness, a new clinical trial finds. “As physicians, we wanted this to make a big difference in reducingContinue Reading

WEDNESDAY, Aug. 18, 2021 (HealthDay News) — Texas Governor Greg Abbott has tested positive for COVID-19 but has not experienced any symptoms, his office announced Tuesday. Abbott, who is fully vaccinated, is being treated with Regeneron’s monoclonal antibodies in an effort to shorten the duration of the infection, his communicationsContinue Reading

TUESDAY, Aug. 17, 2021 (HealthDay News) — There’s strong evidence that the steroid drug dexamethasone can significantly lower hospitalized patients’ risk of dying from COVID-19, but many who might benefit from it the most aren’t getting it. “Dexamethasone is a steroid that is used for the treatment of arthritis, inflammationContinue Reading